ASSESSING EPHA2 AND EPHRIN-A AS NOVEL DIAGNOSTIC AND PROGNOSTIC BIOMARKERS OF PROSTATE CANCER

$679,747FY2014Department of the ArmyDOD

Case Western Reserve University, Cleveland OH

Investigators